Scaling Complex Medical Device Production with Integrated Automation

From Manual Production to High-Level Automation A Fortune 100 medical device manufacturer needed to transition complex, custom-built clinical products from manual production to commercial-scale manufacturing. Facing long development cycles, intensifying pressure to accelerate time to market, and the need to maintain strict GMP compliance throughout, the company required a partner capable of owning both automation […]
Delivering a First-to-Market Thermocycler with Real-Time DNA Amplification and Sequencing for Genetic Analysis

A genomics technology company had a concept for a novel real-time thermocycler that they wanted to bring to market. This special thermocycler would offer 96 individually controlled wells for greater flexibility and precision in DNA amplification and sequencing. Ascential provided full-scale development and contract manufacturing support, helping reduce development time while enabling a first-to-market platform […]
Engineering a Rapid Sepsis Diagnostic Platform to Commercial Scale

From Concept to Commercially Ready: Results in Under 10 Minutes, Time to Market Reduced by 20% A precision diagnostics company developed a cytometry-based sepsis probability platform using advanced machine learning analysis of white blood cells. To bring it to market, they needed an engineering and manufacturing partner capable of delivering the precision automation required for […]
Transforming a Proof-of-Concept Optofluidic Platform into a Commercial-Grade Instrument

From Concept to FDA Breakthrough A precision diagnostics client sought to dramatically reduce the time required to identify effective antibiotics for critically ill patients — without sacrificing accuracy or throughput. Ascential delivered a three-instrument automated system that achieved FDA Breakthrough Device Designation. Faster reagent dispensing across the full testing workflow 0 x Increase in throughput, […]
Sustaining a High-Throughput Genomic Analysis Platform for Long-Term Market Success

From Concept to FDA Breakthrough A precision diagnostics client sought to dramatically reduce the time required to identify effective antibiotics for critically ill patients — without sacrificing accuracy or throughput. Ascential delivered a three-instrument automated system that achieved FDA Breakthrough Device Designation. Faster reagent dispensing across the full testing workflow 0 x Increase in throughput, […]
Scaling a Prototype Research Platform into a Manufacturable, Automated System

From Concept to FDA Breakthrough A precision diagnostics client sought to dramatically reduce the time required to identify effective antibiotics for critically ill patients — without sacrificing accuracy or throughput. Ascential delivered a three-instrument automated system that achieved FDA Breakthrough Device Designation. Faster reagent dispensing across the full testing workflow 0 x Increase in throughput, […]
Delivering a Next-Generation Automated Sample Preparation and Imaging System

From Concept to FDA Breakthrough A precision diagnostics client sought to dramatically reduce the time required to identify effective antibiotics for critically ill patients — without sacrificing accuracy or throughput. Ascential delivered a three-instrument automated system that achieved FDA Breakthrough Device Designation. Faster reagent dispensing across the full testing workflow 0 x Increase in throughput, […]
Automating Pathogen Detection to Rapid Commercial Scale

From Concept to FDA Breakthrough A precision diagnostics client sought to dramatically reduce the time required to identify effective antibiotics for critically ill patients — without sacrificing accuracy or throughput. Ascential delivered a three-instrument automated system that achieved FDA Breakthrough Device Designation. Faster reagent dispensing across the full testing workflow 0 x Increase in throughput, […]
Standard Catheter Steps Ripe for Automation eBook
ROI Realities in Catheter Manufacturing

When catheter manufacturers evaluate process improvements, the conversation typically starts with a simple question: “How much can we save on labor?” But the reality is that labor-only justification rarely drives meaningful returns with high-risk medical device manufacturing. The true ROI comes from addressing bottlenecks in quality, yield, and throughput, as well as the hidden costs […]
